135 related articles for article (PubMed ID: 29625529)
1. Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysema.
Evans R; Brutsche M; Busca R; Deslee G; de Soyza A; Fellrath JM; Franzen D; Hartman J; Mealing S; Morton T; Munavvar M; Sculpher M; Shah P; Slebos DJ; Durand-Zaleski I
Curr Med Res Opin; 2018 Nov; 34(11):1927-1932. PubMed ID: 29625529
[TBL] [Abstract][Full Text] [Related]
2. Do We Need to Assess Quality-of-Life with Both the St George's Respiratory Questionnaire and the EuroQol 5-Dimension Questionnaire in a Clinical Study with an Economic Component: Insights from the REVOLENS Study in Severe Emphysema.
Bulsei J; Pfister J; Leroy S; Perotin JM; Barbe C; Marquette CH; Deslee G; Durand-Zaleski I;
Int J Chron Obstruct Pulmon Dis; 2020; 15():135-142. PubMed ID: 32021152
[TBL] [Abstract][Full Text] [Related]
3. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.
Sciurba FC; Criner GJ; Strange C; Shah PL; Michaud G; Connolly TA; Deslée G; Tillis WP; Delage A; Marquette CH; Krishna G; Kalhan R; Ferguson JS; Jantz M; Maldonado F; McKenna R; Majid A; Rai N; Gay S; Dransfield MT; Angel L; Maxfield R; Herth FJ; Wahidi MM; Mehta A; Slebos DJ;
JAMA; 2016 May 24-31; 315(20):2178-89. PubMed ID: 27179849
[TBL] [Abstract][Full Text] [Related]
4. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
Yang F; Devlin N; Luo N
Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
[TBL] [Abstract][Full Text] [Related]
5. Protocol of a Randomized Controlled Study of the PneumRx Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema (ELEVATE).
Herth FJF; Slebos DJ; Shah PL; Hetzel M; Schmid-Bindert G; LaPrad AS; Deslée G; Valipour A
Respiration; 2019; 98(6):512-520. PubMed ID: 31743933
[TBL] [Abstract][Full Text] [Related]
6. Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial.
Griffiths A; Paracha N; Davies A; Branscombe N; Cowie MR; Sculpher M
Adv Ther; 2017 Mar; 34(3):753-764. PubMed ID: 28205056
[TBL] [Abstract][Full Text] [Related]
7. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.
Deslée G; Mal H; Dutau H; Bourdin A; Vergnon JM; Pison C; Kessler R; Jounieaux V; Thiberville L; Leroy S; Marceau A; Laroumagne S; Mallet JP; Dukic S; Barbe C; Bulsei J; Jolly D; Durand-Zaleski I; Marquette CH;
JAMA; 2016 Jan; 315(2):175-84. PubMed ID: 26757466
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema.
Klooster K; Valipour A; Marquette CH; Boutros J; Mal H; Marceau A; Shah PL; Conway F; Deslée G; Bourdin A; Pison C; Grah C; Hetzel M; Schumann C; Kessler R; Huebner RH; Skowasch D; Darwiche K; Hammerl P; Stanzel F; Bezzi M; Dutau H; Herth FJF; Slebos DJ
Respiration; 2021; 100(8):804-810. PubMed ID: 33965944
[TBL] [Abstract][Full Text] [Related]
9. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
[TBL] [Abstract][Full Text] [Related]
10. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.
McDaid C; Griffin S; Weatherly H; Durée K; van der Burgt M; van Hout S; Akers J; Davies RJ; Sculpher M; Westwood M
Health Technol Assess; 2009 Jan; 13(4):iii-iv, xi-xiv, 1-119, 143-274. PubMed ID: 19103134
[TBL] [Abstract][Full Text] [Related]
11. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
12. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.
Rowen D; Young T; Brazier J; Gaugris S
Value Health; 2012 Dec; 15(8):1059-68. PubMed ID: 23244808
[TBL] [Abstract][Full Text] [Related]
13. Long-term quality-adjusted survival following therapeutic bronchoscopy for malignant central airway obstruction.
Ong P; Grosu HB; Debiane L; Casal RF; Eapen GA; Jimenez CA; Noor L; Ost DE
Thorax; 2019 Feb; 74(2):141-156. PubMed ID: 30254139
[TBL] [Abstract][Full Text] [Related]
14. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
15. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema.
Slebos DJ; Klooster K; Ernst A; Herth FJF; Kerstjens HAM
Chest; 2012 Sep; 142(3):574-582. PubMed ID: 22116796
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.
Huang R; Rao H; Shang J; Chen H; Li J; Xie Q; Gao Z; Wang L; Wei J; Jiang J; Sun J; Jiang J; Wei L
Health Qual Life Outcomes; 2018 Jun; 16(1):124. PubMed ID: 29903024
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea.
Lee MY; Park SK; Park SY; Byun JH; Lee SM; Ko SK; Lee EK
Clin Ther; 2015 Aug; 37(8):1662-76.e2. PubMed ID: 26243076
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of an extended nutritional intervention in older Australian hospitalized patients: a randomized controlled trial.
Sharma Y; Thompson C; Miller M; Shahi R; Hakendorf P; Horwood C; Kaambwa B
BMC Geriatr; 2018 Feb; 18(1):41. PubMed ID: 29402228
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of utility index of quality of life (QOL) in prostate cancer patients: comparison of QOL utility index EuroQol-5D (EQ-5D) and visual analogue scale (VAS) with health-related QOL questionnaires SF-36 and EPIC].
Akakura K; Matsuzaki K; Kobayashi T; Kitoh H; Mizoguchi K; Tomikawa G; Takura T; Kawabuchi K
Nihon Hinyokika Gakkai Zasshi; 2011 Jan; 102(1):9-13. PubMed ID: 21520631
[TBL] [Abstract][Full Text] [Related]
20. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.
Joore M; Brunenberg D; Nelemans P; Wouters E; Kuijpers P; Honig A; Willems D; de Leeuw P; Severens J; Boonen A
Value Health; 2010; 13(2):222-9. PubMed ID: 19878492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
